0.5 Mg Trametinib Tablets

Name: 0.5 Mg Trametinib Tablets
Brand: NEETCO BIOPHARMA
Price: 48000 INR
Availability: InStock

Price 48000 INR/ Box

Get a Price/Quote

MOQ : 1 Box

0.5 Mg Trametinib Tablets Specification

Dosage Form
Tablet

Salt Composition
Trametinib 0.5 mg

Indication
Treatment of melanoma and certain types of solid tumors

Enzyme Types
MEK inhibitor

Feature
Oral use, convenient dosage, precisely measured strength

Ingredients
Trametinib, inactive excipients

Application
Prescription anti-cancer medication

Physical Color/Texture
Yellow, film-coated tablet

Fermentation Smell
Odorless

Enzymatic Activity
Inhibits MEK1 and MEK2 enzymes (kinase inhibitor activity)

Storage Instructions
Store below 30°C in original packaging, protect from light and moisture

Shelf Life
24 months

Regulatory Status
Approved by relevant regulatory authorities (e.g., FDA, EMA)

Route of Administration
Oral

Packaging Size
30 tablets per bottle/blister pack

Strength
0.5 mg per tablet

Contraindications
Known hypersensitivity to Trametinib or any excipients

Administration
Take orally, once daily or as directed by physician

Prescription Status
Rx only

About 0.5 Mg Trametinib Tablets

Explore the supreme efficacy of 0.5 mg Trametinib Tablets-a crackerjack solution for advanced melanoma and certain solid tumors. These venerable, premium-quality tablets offer exclusive clinical benefits and come in a convenient 30-tablet, yellow film-coated pack. Administered orally once daily as directed by your physician, Trametinib 0.5 mg ensures precise dosing and unmatched convenience. Boasting a proven record and regulatory approvals (FDA, EMA), this Rx-only MEK inhibitor is manufactured, distributed, and exported from India. Store below 30C, in original packaging, away from light and moisture, for optimal potency. Exclusively available for global sourcing and trusted by medical professionals.

Application Expertise: Who Benefits from 0.5 Mg Trametinib Tablets?

0.5 Mg Trametinib Tablets are prescribed primarily for adults facing melanoma and specific solid tumors. Oncology specialists and healthcare institutions rely on its MEK inhibition for targeting abnormal cell signaling. The competitive advantages include precisely measured doses, oral convenience, and a reputable regulatory history, setting it apart as a preferred choice in cancer treatment regimes. This marks Trametinib as a sophisticated and trusted option for both patients and practitioners seeking advanced targeted therapy.

Delivery Exchange: Supply Capabilities and Domestic Reach

0.5 Mg Trametinib Tablets are delivered from premium Indian facilities and shipped worldwide. The major ports for FOB exchange include Mumbai and Chennai, ensuring timely availability. Serving the main domestic markets across India, the tablets maintain a consistent supply with flexible order quantities to meet commercial and clinical needs. Customers benefit from reliable and prompt deliveries, tailored for distributors and traders seeking a steadfast anti-cancer medication exchange network.

FAQ's of 0.5 Mg Trametinib Tablets:

Q: How should 0.5 mg Trametinib Tablets be administered for optimum results?

A: These tablets should be taken orally, once daily, exactly as prescribed by your physician. Do not exceed or alter the dosage unless advised by your healthcare provider.

Q: What conditions are 0.5 mg Trametinib Tablets indicated for?

A: 0.5 mg Trametinib Tablets are used in the treatment of melanoma and certain types of solid tumors, leveraging MEK inhibitor activity to target abnormal cell signaling.

Q: When should Trametinib treatment be avoided?

A: Avoid Trametinib if you have a known hypersensitivity to the drug or any of its excipients, as severe allergic reactions may occur.

Q: Where are these tablets manufactured and shipped from?

A: These tablets are manufactured, distributed, and exported from India, and are shipped via major ports like Mumbai and Chennai to both domestic and international buyers.